Loading…

Protocol - Herpes Simplex Virus Types 1 and 2 - Assay

Add to My Toolkit
Description

This protocol provides information for drawing, processing, and storing blood for the herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) assay according to National Health and Nutrition Examination Survey (NHANES) methods. HSV-1 and HSV-2 are measured using the Solid-Phase Enzymatic Immunodot method.

Specific Instructions

None

Availability

Available

Protocol

The following is a summary version of the full National Health and Nutrition Examination Survey (NHANES) 2007–2008 protocol.

Exclusion Criteria

Persons will be excluded from this component if they:

  • report that they have hemophilia, or
  • report that they have received cancer chemotherapy in the last 4 weeks.

SP = Sample Person

1. Do you have hemophilia?

1[ ]Yes

2[ ]No

7[ ]Refused

9[ ]Dont Know

If the SP answers "Yes," the SP is excluded from the blood draw.

If the SP answers "No" or "Dont Know," blood is drawn from the SP.

2. Have you received cancer chemotherapy in the past 4 weeks, or do you anticipate such therapy in the next 4 weeks?

1[ ]Yes

2[ ]No

7[ ]Refused

9[ ]Dont Know

If the SP answers "Yes," the SP is excluded from the blood draw.

If the SP answers "No" or "Dont Know," blood is drawn from the SP.

Note from the Infectious Diseases and Immunity Working Group (WG): The investigator should record the reason a person is excluded from the blood draw.

Venipuncture Procedures

Editors Note: Please review chapter 4 of the Laboratory Procedures Manual from the NHANES for a full description of phlebotomy procedures: 2007-2008 NHANES Lab Manual.

Venipuncture should generally be performed using the median cubital, cephalic, or basilica veins in the left arm unless this arm is unsuitable. If the veins in the left arm are unsuitable, look for suitable veins on the right arm. If the veins in the antecubital space on both arms are not suitable, then look for veins in the forearm or dorsal side of the hand on the left arm/hand and then right arm/hand.

Recording the Results of the Venipuncture Procedure

Immediately after completing the venipuncture, record the results of the blood draw, the reasons for a tube not being drawn according to the protocol, and any comments about the venipuncture.

Note from the Infectious Diseases and Immunity WG: The Infectious Diseases and Immunity WG recommends that the investigator record whether the blood was drawn and whether the full amount was obtained.

Process the Sample for the Serum

Editors Note: Please review chapter 8 of the Laboratory Procedures Manual from the NHANES 2007–2008 for a full description of blood processing procedures: 2007-2008 NHANES Lab Manual.

  • Allow the blood to clot by setting aside for 30–45 minutes at room temperature. Do not clot for more than 1 hour.
  • Centrifuge the tube at room temperature to separate the serum and aliquot into an appropriate storage tube.
  • Determine if the serum is hemolyzed, turbid, lipemic, or icteric. If so, enter a comment to describe the plasma.

Laboratory Assay for Herpes Simplex Virus Type 1

The Infectious Diseases and Immunity WG recommends that herpes simplex virus type 1 and type 2 in serum be determined according to the Solid-Phase Enzymatic Immunodot assay used in the NHANES: Herpes Simplex Virus Types 1 and 2

To aid comparability, the Infectious Diseases and Immunity WG recommends that the investigator record the make and manufacturer of equipment used and the repeatability and coefficients of variation for the assay.

Personnel and Training Required

Phlebotomist

Laboratory that can perform the Solid-Phase Enzymatic Immunodot assay

Equipment Needs

Phlebotomy supplies

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Bioassay

Lifestage

Adolescent, Adult

Participants

Adolescents and adults, aged 14-49 years of age

Selection Rationale

The National Health and Nutrition Examination Survey (NHANES) 2007-2008 protocol was selected as the best practice methodology and one of the most widely used protocols to measure herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). This method has proven to be accurate, robust, and reproducible.

Language

Chinese, English, Other languages available at source

Standards
StandardNameIDSource
Logical Observation Identifiers Names and Codes (LOINC) Assay herpes simplex 1-2 proto 62873-5 LOINC
Human Phenotype Ontology Congenital Herpes Simplex Virus Infection ORPHA:293 HPO
caDSR Form PhenX PX160501 - Assay For Herpes Simplex Virus Types 1 And 2 6185175 caDSR Form
Derived Variables

None

Process and Review

Not applicable.

Protocol Name from Source

National Health and Nutrition Examination Survey Questionnaire (NHANES), Laboratory Procedures Manual, 2007

Source

Centers for Disease Control and Prevention (CDC). (2007). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Emory University Division of Infectious Diseases, Immunology and Epidemiology Laboratory Procedures Manual for Herpes Simplex Virus Type 1 by Solid-Phase Enzymatic Immunodot. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). (2007). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

General References

Lee, F. K., Pereira, L., & Griffin, C. (1986). A novel glycoprotein for detection of herpes simplex virus type 1–specific antibodies. Journal of Virological Methods, 14, 111–118.

Protocol ID

160501

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
PX160501_Assay_Repeatability
PX160501080000 Repeatability of the assay N/A
PX160501_Blood_Draw_Comments
PX160501040200 Record any comments about the blood draw, more
including any reasons for the tube not being drawn according to the protocol. show less
Variable Mapping
PX160501_Blood_Draw_Done
PX160501040000 Was blood drawn? Variable Mapping
PX160501_Blood_Draw_Sample
PX160501040100 Was full amount obtained? N/A
PX160501_Chemotherapy
PX160501020000 Have you received cancer chemotherapy in the more
past four weeks or do you anticipate such therapy in the next four weeks? (exclusion from Phlebotomy) show less
Variable Mapping
PX160501_Coefficient_Of_Variation
PX160501090000 Coefficient of variation for the assay N/A
PX160501_Equipment_Make
PX160501070100 Make of the equipment used to perform the more
HSV assay. show less
N/A
PX160501_Equipment_Manufacturer
PX160501070200 Manufacturer of the equipment used to more
perform the HSV assay. show less
N/A
PX160501_Exclusion_Criteria
PX160501030000 Exclusion Criteria N/A
PX160501_Hemophilia
PX160501010000 Do you have hemophilia? (exclusion from more
Phlebotomy) show less
Variable Mapping
PX160501_HSV_Assay_Type
PX160501060000 Record the type of assay used for HSV testing. N/A
PX160501_HSV_Type1_Assay_Results
PX160501100000 HSV Type 1 assay results N/A
PX160501_HSV_Type2_Assay_Results
PX160501110000 HSV Type 2 assay results N/A
PX160501_Sample_Comments
PX160501050000 Record any comments about the sample during more
processing. show less
Variable Mapping
Infectious Diseases and Immunity
Measure Name

Herpes Simplex Virus Types 1 and 2 Assay

Release Date

November 12, 2010

Definition

This is a bioassay to measure herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). HSV-1 causes infections of the lips and mouth, such as cold sores and fever blisters. It is transmitted through saliva. Both HSV-1 and HSV-2 can cause genital herpes, a sexually transmitted disease (STD). Most genital herpes is caused by HSV-2.

Purpose

The bioassay determines whether a participant is infected with herpes simplex virus type 1 (HSV-1) and/or type 2 (HSV-2), a common infection in the United States. A total of 16.2%, or about one out of six people aged 14–49 years of age, have genital HSV-2 infection.

Keywords

Infectious disease, Sexually transmitted disease, Herpes simplex virus, National Health and Nutrition Examination Survey, NHANES, Infectious Diseases and Immunity

Measure Protocols
Protocol ID Protocol Name
160501 Herpes Simplex Virus Types 1 and 2 - Assay
Publications

There are no publications listed for this protocol.